{"gene":"CNTF","run_date":"2026-06-09T22:57:18","timeline":{"discoveries":[{"year":1989,"finding":"CNTF was purified from rabbit sciatic nerve and cloned; biologically active CNTF was expressed from a cDNA clone, establishing it as a distinct neural effector protein with no significant sequence homology to previously known proteins including NGF.","method":"Protein purification, cDNA cloning, transient expression assay","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct biochemical purification, cloning, and functional expression in a foundational paper replicated extensively","pmids":["2587985"],"is_preprint":false},{"year":1992,"finding":"CNTF and LIF share signaling pathways in neuronal cells that involve the IL-6 signal transducing receptor component gp130; CNTF induces the same tyrosine phosphorylations and gene activations as LIF and IL-6 in hematopoietic cells, demonstrating that CNTF signals via a cytokine-type receptor rather than a receptor tyrosine kinase.","method":"Tyrosine phosphorylation assays, gene activation assays, receptor component characterization in neuronal and hematopoietic cell lines","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (phosphorylation, gene activation, receptor characterization), replicated by subsequent studies","pmids":["1617725"],"is_preprint":false},{"year":1993,"finding":"The CNTF receptor complex is tripartite, consisting of the CNTF-specific binding protein CNTFRα plus LIFR-β and gp130; CNTF and LIF both trigger association of initially separate receptor components leading to tyrosine phosphorylation of receptor subunits; signaling requires heterodimerization of gp130 with LIFRβ (unlike IL-6 which uses gp130 homodimerization).","method":"Receptor reconstitution, co-immunoprecipitation, tyrosine phosphorylation assays, cell-based signaling assays","journal":"Science","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — reconstitution of receptor complex, reciprocal functional assays, replicated across multiple labs","pmids":["8390097"],"is_preprint":false},{"year":1993,"finding":"CNTFRα is a required receptor component that confers CNTF responsiveness; transfection of CNTFRα into hematopoietic cells normally responsive only to LIF was sufficient to render them CNTF-responsive, demonstrating CNTFRα is necessary and sufficient for CNTF target cell specification.","method":"Gene transfection, cell-based CNTF response assay, immunolocalization","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — gain-of-function transfection experiment with clear cellular readout, replicated conceptually across studies","pmids":["8381290"],"is_preprint":false},{"year":1993,"finding":"CNTFRα is anchored by a GPI linkage and can be released as a soluble form; soluble CNTFRα can function as part of a heterodimeric ligand with CNTF to activate cells lacking membrane-bound CNTFRα, and is present in cerebrospinal fluid and released from skeletal muscle upon peripheral nerve injury.","method":"Cell-based responsiveness assays with soluble CNTFRα, CSF analysis, muscle denervation model","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — functional reconstitution with soluble receptor, multiple cell line validations, in vivo detection","pmids":["7681218"],"is_preprint":false},{"year":1994,"finding":"The beta receptor components gp130 and LIFRβ constitutively associate with Jak/Tyk family cytoplasmic tyrosine kinases; ligand-induced dimerization of these receptor beta components activates the kinases; CNTF receptor utilizes all known members of the Jak/Tyk family but induces distinct phosphorylation patterns in different cell lines.","method":"Co-immunoprecipitation of receptor–kinase complexes, tyrosine phosphorylation assays, kinase activation assays","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP demonstrating constitutive association, activation by ligand-induced dimerization, replicated","pmids":["8272873"],"is_preprint":false},{"year":1994,"finding":"CNTF assembles its tripartite receptor in a stepwise fashion: CNTF first binds CNTFRα, then recruits gp130, and finally complexes with LIFRβ; heterodimerization of the beta components activates JAK/TYK kinases that are preassociated with beta components in an inactive state, which in turn activate STAT family transcription factors.","method":"Biochemical receptor assembly assays, kinase activation analysis, signaling pathway characterization","journal":"Journal of neurobiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — mechanistic dissection of stepwise receptor assembly and downstream kinase-STAT pathway, consistent with multiple independent studies","pmids":["7852997"],"is_preprint":false},{"year":1994,"finding":"Human CNTF null mutation (G to A transition creating a new splice acceptor site) produces only aberrant mRNA and no functional protein; 2.3% of Japanese individuals are homozygous for this mutation, but CNTF deficiency is not causally related to neurological diseases.","method":"Genomic sequencing, minigene transfection into cultured cells, mRNA analysis, population genotyping","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — minigene transfection demonstrating exclusive mutant mRNA expression, large population study; negative finding for disease causation is robust","pmids":["8075647"],"is_preprint":false},{"year":1994,"finding":"Recombinant soluble CNTFRα forms a 1:1 stoichiometric complex with CNTF; soluble CNTFRα reconstitutes active complexes on the surface of cells lacking membrane CNTFRα with the same relative ligand specificity and affinity as the cell-surface receptor.","method":"Size-exclusion chromatography, protein gel-shift assay, cell-based survival assays with TF-1 cells","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — quantitative biochemical reconstitution with defined stoichiometry and functional validation","pmids":["8180210"],"is_preprint":false},{"year":1995,"finding":"Mice lacking CNTFRα die perinatally with severe motor neuron deficits, whereas mice lacking CNTF itself have no notable developmental neurological abnormalities, demonstrating that CNTFRα serves as receptor for a second developmentally important CNTF-like ligand distinct from CNTF.","method":"Gene knockout (null mutation), comparative phenotypic analysis of CNTF-/- vs CNTFRα-/- mice","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct comparison of two knockout models with clear phenotypic divergence, establishing CNTFRα's role beyond CNTF signaling","pmids":["7585948"],"is_preprint":false},{"year":1995,"finding":"The D-helix region of CNTF (particularly Gln167) is important for CNTFRα binding; phage display-selected variants with substitutions at Gln167 showed greatly increased CNTFRα affinity and enhanced neurotrophic activity via CNTFRα, but did not potentiate CNTFRα-independent receptor actions, demonstrating this region is a functional site for CNTFRα interaction.","method":"Phage display affinity maturation, in vitro binding assays, cell-based biological activity assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis combined with phage display selection and functional validation in cell-based assays","pmids":["7621819"],"is_preprint":false},{"year":1996,"finding":"Residues F152 and K155 in the D1 motif of human CNTF are essential for interaction with LIFRβ; alanine substitution of either residue specifically inhibited CNTF interaction with LIFR without affecting binding to CNTFRα or gp130; combined F152A/K155A substitution abolished biological activity; combining these with CNTFRα-affinity enhancing mutations in the D-helix generated a potent competitive CNTF receptor antagonist.","method":"Alanine-scanning mutagenesis, in vitro binding assays, cell-based bioactivity assays","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 1 / Moderate — systematic alanine mutagenesis with orthogonal binding and functional readouts identifying distinct receptor-binding sites","pmids":["8799186"],"is_preprint":false},{"year":1996,"finding":"Simultaneous inactivation of both CNTF and LIF genes in mice produces more extensive and earlier-appearing motoneuron degeneration than CNTF knockout alone, accompanied by reduced grip strength, revealing cryptic physiological trophic support by LIF for motoneurons that is unmasked only when CNTF is also absent.","method":"Double gene knockout (CNTF-/- / LIF-/-), quantitative motoneuron analysis, functional grip strength testing","journal":"Current biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis via double knockout with quantitative cellular and functional readouts","pmids":["8793295"],"is_preprint":false},{"year":2000,"finding":"CLC (cardiotrophin-like cytokine) forms a stable secreted heteromeric complex with the soluble receptor CLF; CLF expression is required for CLC secretion; the CLF/CLC complex acts only on cells expressing functional CNTF receptors, activates gp130, LIFRβ, and STAT3, and supports motor neuron survival, identifying it as a second ligand for CNTFRα.","method":"Co-expression/secretion assays, cell-based signaling assays (STAT3 activation), motor neuron survival assays, receptor specificity tests","journal":"Nature neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods demonstrating complex formation, receptor specificity, and functional consequences","pmids":["10966616"],"is_preprint":false},{"year":2000,"finding":"CNTF-induced serine phosphorylation of STAT3 at Ser727 (required for maximal STAT3 transcriptional activation) is mediated by mTOR, not by MAPK or PKC; mTOR directly phosphorylated a STAT3 Ser727 peptide in a CNTF-dependent manner, and kinase-inactive mTOR mutant failed to do so; rapamycin inhibited this phosphorylation and a STAT3 Ser727Ala mutant reduced reporter activation equivalently.","method":"In vitro kinase assay with mTOR, pharmacological inhibition (rapamycin, MAPK inhibitors, PKC inhibitors), dominant-negative mTOR mutant, STAT3 reporter assay with Ser727Ala mutant","journal":"Current biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with mutagenesis and pharmacological validation, mechanistically rigorous single study","pmids":["10660304"],"is_preprint":false},{"year":2000,"finding":"Reg-2/PAP I is induced by CNTF-related cytokines in motoneurons and functions as an obligatory intermediate in the CNTF survival signaling pathway; blocking Reg-2 expression via antisense adenovirus specifically abrogated the survival effect of CNTF on cultured motoneurons; Reg-2 itself acts as an autocrine/paracrine neurotrophic factor via PI3K-Akt-NF-κB signaling.","method":"Antisense adenovirus knockdown, cultured motoneuron survival assay, purified Reg-2 survival assay, pathway inhibitor studies (PI3K, Akt, NF-κB)","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — loss-of-function knockdown with specific survival readout and pathway characterization","pmids":["11146655"],"is_preprint":false},{"year":2003,"finding":"Human CNTF can use both membrane-bound and soluble human IL-6Rα as a substitute for its cognate CNTFRα to widen its target cell spectrum; unlike rat CNTF, human CNTF cannot directly induce a heterodimer of human gp130 and LIFRβ in the absence of an alpha receptor.","method":"Cell-based signaling assays, receptor competition assays, chimeric receptor constructs","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — cell-based functional assays, single lab study","pmids":["12643274"],"is_preprint":false},{"year":2005,"finding":"Triple knockout of CNTF, LIF, and CT-1 in mice reveals cooperative but distinct roles: LIF deficiency leads to pronounced loss of distal axons and motor endplate alterations, whereas CNTF and CT-1 deficiency does not cause significant changes in these structures; triple knockout mice show increased motoneuron cell loss correlating with early postnatal muscle weakness.","method":"Triple and combined double knockout mouse models, quantitative motoneuron counting, morphological analysis of axons and motor endplates, grip strength testing","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Moderate — systematic multi-gene knockout with quantitative cellular and functional readouts distinguishing individual ligand contributions","pmids":["15716414"],"is_preprint":false},{"year":2006,"finding":"CNTF reverses obesity-induced insulin resistance by signaling through the CNTFRα-IL-6R-gp130β receptor complex in skeletal muscle to activate AMPK, increase fatty-acid oxidation, and reduce insulin resistance independent of central (brain) signaling.","method":"In vivo skeletal muscle AMPK activation assays, receptor complex characterization, peripheral (skeletal muscle-specific) vs. central pathway dissection","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 / Moderate — defined receptor complex, AMPK activation assay in skeletal muscle, brain-independent mechanism demonstrated","pmids":["16604088"],"is_preprint":false},{"year":2007,"finding":"Astrocyte-derived CNTF is a major mediator of the neuroprotective and axon-growth-promoting effects of lens injury (intraocular inflammation) on retinal ganglion cells; CNTF from retinal astrocytes activates STAT3 in RGCs; antibody neutralization of CNTF or JAK inhibition compromised the beneficial effects of lens injury, while anti-oncomodulin was ineffective.","method":"Intravitreal antibody neutralization, JAK inhibitor treatment, in vivo RGC regeneration assay, STAT3 phosphorylation immunostaining, CNTF-/- mouse comparison","journal":"Brain","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple loss-of-function approaches (antibody, pharmacological inhibitor) with specific cellular readouts in vivo","pmids":["17971355"],"is_preprint":false},{"year":2009,"finding":"Humanin (HN) protects neurons by binding to a receptor complex involving CNTFRα, WSX-1, and gp130; HN induces hetero-oligomerization of these three subunits in vitro; siRNA knockdown of CNTFRα or WSX-1 reduced HN binding and abolished neuroprotection, while overexpression of CNTFRα and/or WSX-1 upregulated HN binding.","method":"In vitro reconstituted binding assay, siRNA knockdown, receptor overexpression, loss-of-function cell-based protection assay","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — in vitro reconstitution plus siRNA knockdown, single lab study on a secondary ligand (HN) using CNTFRα","pmids":["19386761"],"is_preprint":false},{"year":2009,"finding":"Exogenous CNTF stimulates RGC axon outgrowth in vitro via JAK/STAT3 and PI3K/AKT signaling pathways; in vivo, exogenously applied CNTF induces endogenous CNTF expression in astrocytes via MAPK/ERK pathway activation; reduction of endogenous CNTF or its absence in CNTF-/- mice markedly reduces the neurite growth-promoting effects of exogenous CNTF.","method":"In vitro neurite outgrowth assay with pathway inhibitors, in vivo CNTF-/- mice, MAPK/ERK pathway inhibitors in vivo, endogenous CNTF mRNA quantification","journal":"Molecular and cellular neurosciences","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic (CNTF-/- mice) and pharmacological loss-of-function with in vitro and in vivo readouts, mechanistic pathway identification","pmids":["19332123"],"is_preprint":false},{"year":2009,"finding":"CNTF signals through JAK2/STAT3 cascade in pancreatic islets, increases SOCS3 expression, and protects neonatal rat islets from cytokine-induced apoptosis; these effects were blocked by JAK inhibitor AG490 and STAT3 inhibitor curcumin but not by MAPK or PI3K inhibitors.","method":"Pharmacological pathway inhibitors, Western blot for STAT3/Akt/ERK phosphorylation, RT-PCR for SOCS3, apoptosis assays","journal":"Cytokine","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — pharmacological inhibition with Western blot readouts, single lab, no genetic validation","pmids":["19272793"],"is_preprint":false},{"year":2012,"finding":"Endogenous CNTF mediates stroke-induced neurogenesis in the adult mouse SVZ; CNTF-/- mice lack stroke-induced SVZ proliferation; CNTF appears to act on C cell proliferation and by inducing FGF2 expression but not via EGF or Notch1 signaling.","method":"CNTF-/- mice, BrdU proliferation assay, middle cerebral artery occlusion model, FGF2/EGF/Notch1 expression analysis","journal":"Neurobiology of disease","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic knockout with specific cellular readout and downstream pathway characterization","pmids":["22960105"],"is_preprint":false},{"year":2013,"finding":"CNTF expression in astrocytes is repressed by neuronal contact via an αvβ5 integrin–FAK–JNK signaling pathway; FAK phosphorylates STAT3 on inhibitory Ser-727 to interfere with pro-transcriptional Tyr-705 activity; blockade of FAK or JNK rapidly induces CNTF mRNA and protein; neuronal surface protein Thy1 acts as a neuroglial CNTF repressor; STAT3 binds the CNTF promoter and mediates FAK antagonist-induced CNTF expression.","method":"Integrin-specific antibodies, FAK/JNK/ERK/p38 inhibitors, co-culture experiments, STAT3 chromatin immunoprecipitation, microinjection of FAK inhibitor in vivo, neurogenesis assay","journal":"Cell communication and signaling","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal approaches (antibody, pharmacological, ChIP, in vivo injection) in a single mechanistic study","pmids":["23693126"],"is_preprint":false},{"year":2018,"finding":"Hypothalamic CRH neurons innervate ependymal cells of the 3rd ventricle to induce CNTF release; CNTF is transported through the brain's aqueductal system (volume transmission) and binds receptors on locus coeruleus norepinephrinergic neurons; CNTF then initiates sequential phosphorylation of ERK1 and tyrosine hydroxylase (gated by the Ca2+-sensor secretagogin); both CNTF and secretagogin ablation blocked stress-induced cortical norepinephrine synthesis and associated behavioral responses.","method":"Neuroanatomical tract tracing, CNTF and secretagogin conditional knockout/ablation, phosphorylation assays (ERK1, tyrosine hydroxylase), behavioral assays, human brain tissue validation","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic ablation models combined with biochemical phosphorylation assays, in vivo pathway and behavioral readouts, validated in human brain","pmids":["30209240"],"is_preprint":false},{"year":2020,"finding":"CNTF from Schwann cells mediates neuroinflammation in sensory neurons via STAT3 activation and consequent IL-6 induction, propagating the inflammatory cascade from the periphery to the spinal cord; CNTF deficiency attenuates neuroinflammation in DRG and spinal cord with reduced pain; recombinant CNTF applied to sensory nerves recapitulates this neuroinflammatory cascade.","method":"CNTF-/- mice, recombinant CNTF application, pain behavioral assays, STAT3 phosphorylation assays, IL-6 quantification in DRG and spinal cord","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic knockout combined with gain-of-function (recombinant CNTF) and mechanistic signaling readouts (STAT3, IL-6)","pmids":["32433966"],"is_preprint":false},{"year":2021,"finding":"CNTF gene therapy promotes optic nerve regeneration partially indirectly through immune mediators: deletion of CNTFRα specifically in RGCs did not diminish the regeneration-promoting effect of CNTF gene therapy, but neutrophil depletion or suppression of monocyte infiltration did; CNTF gene therapy increased CCL5 expression in immune cells and retinal glia, and CCL5 acting through CCR5 on RGCs mediates much of the regenerative effect.","method":"Conditional CNTFRα knockout in RGCs (CRISPR), neutrophil depletion, monocyte infiltration suppression, recombinant CCL5 injection, CRISPR CCR5 knockdown in RGCs, CCR5 antagonist treatment, axon regeneration quantification","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic and pharmacological loss-of-function approaches with specific mechanistic readouts, convergent evidence identifying indirect CCL5-CCR5 pathway","pmids":["33627402"],"is_preprint":false},{"year":2002,"finding":"CNTF enhances myelination by acting on oligodendrocytes to favor their final maturation; this promyelinating effect is mediated through the gp130 receptor common to the CNTF family and transduced through the JAK kinase pathway.","method":"Enzymatic myelination index assay, receptor pathway pharmacological blockade (JAK inhibitor), oligodendrocyte culture assays","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — cell culture assay with pharmacological pathway inhibition, single lab","pmids":["12417647"],"is_preprint":false},{"year":2009,"finding":"In adult zebrafish retina, CNTF utilizes a MAPK-dependent signaling pathway (not Stat3 or Akt) for neuroprotection of light-induced photoreceptor cell death, while it uses a Stat3-dependent pathway (not MAPK or Akt) to stimulate Müller glia proliferation; these two CNTF-mediated processes use distinct intracellular signaling cascades.","method":"Intraocular injection, pathway-specific inhibitors (MAPK, Stat3, Akt), Stat3 morpholino knockdown, light-damage model, cell proliferation quantification","journal":"Experimental eye research","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — pharmacological inhibition and morpholino knockdown in vivo, single lab, zebrafish model","pmids":["19450453"],"is_preprint":false}],"current_model":"CNTF is a secreted cytokine (expressed primarily by Schwann cells and astrocytes) that assembles a tripartite receptor complex by sequentially binding GPI-anchored CNTFRα, then recruiting gp130 and LIFRβ; heterodimerization of the beta-receptor components activates preassociated JAK/TYK kinases, which phosphorylate STAT3 (at Tyr705 via JAKs and at Ser727 via mTOR) and activate MAPK and PI3K-AKT pathways to promote neuronal survival, axon regeneration, oligodendrocyte myelination, and skeletal muscle AMPK activation; soluble CNTFRα can act as a diffusible cofactor to extend CNTF responsiveness to cells lacking membrane-bound CNTFRα; in vivo, CNTF can also act indirectly by inducing downstream mediators such as Reg-2 in motoneurons, CCL5 in retinal immune/glial cells, and FGF2 in astrocytes, and hypothalamic CNTF volume transmission links stress-induced CRH signaling to locus coeruleus norepinephrine synthesis via sequential ERK1 and tyrosine hydroxylase phosphorylation."},"narrative":{"mechanistic_narrative":"CNTF is a secreted neural cytokine, originally purified from sciatic nerve, that signals through a cytokine-type receptor rather than a receptor tyrosine kinase [PMID:2587985, PMID:1617725]. It assembles a tripartite receptor by first binding the ligand-specific, GPI-anchored CNTFRα and then recruiting gp130 and LIFRβ, whose heterodimerization (distinct from the gp130 homodimerization used by IL-6) drives signaling [PMID:8390097, PMID:7852997]; CNTFRα is both necessary and sufficient to confer CNTF responsiveness on otherwise unresponsive cells [PMID:8381290]. Distinct surface determinants on CNTF mediate these contacts — a D-helix region (Gln167) for CNTFRα and residues F152/K155 for LIFRβ — and mutations combining enhanced CNTFRα affinity with disrupted LIFRβ binding yield a competitive antagonist [PMID:7621819, PMID:8799186]. Because CNTFRα can be shed as a soluble form that forms a 1:1 complex with CNTF and reconstitutes signaling on cells lacking membrane receptor, CNTF activity can be extended in a paracrine manner, including following nerve injury [PMID:7681218, PMID:8180210]. The dimerized beta receptors activate constitutively associated JAK/TYK kinases, which in turn activate STAT3; maximal STAT3 transcriptional activity additionally requires Ser727 phosphorylation contributed by mTOR, alongside PI3K/AKT and MAPK/ERK outputs [PMID:8272873, PMID:7852997, PMID:10660304, PMID:19332123]. Through these cascades CNTF supports motoneuron survival, retinal ganglion cell axon regeneration, oligodendrocyte myelination, and adult neurogenesis, and it acts peripherally on skeletal muscle to activate AMPK and reverse insulin resistance [PMID:8793295, PMID:17971355, PMID:12417647, PMID:22960105, PMID:16604088]. Several CNTF effects are relayed indirectly through induced mediators — Reg-2 in motoneurons, FGF2 in the subventricular zone, and a CCL5–CCR5 axis engaging immune cells during optic nerve regeneration [PMID:11146655, PMID:22960105, PMID:33627402]. CNTFRα additionally serves as a shared receptor component for other ligands including the CLF/CLC complex and humanin, and CNTFRα-null mice die perinatally with motoneuron deficits far exceeding those of CNTF-null mice, indicating an essential CNTFRα ligand beyond CNTF itself [PMID:7585948, PMID:10966616, PMID:19386761]. A human CNTF null mutation is common in some populations yet is not causally linked to neurological disease, consistent with genetic redundancy among CNTF, LIF, and CT-1 in trophic support of motoneurons [PMID:8075647, PMID:8793295, PMID:15716414].","teleology":[{"year":1989,"claim":"Establishing CNTF's molecular identity was the prerequisite to any mechanistic work; purification and cloning defined it as a distinct neural effector protein unrelated to known neurotrophins.","evidence":"Protein purification from rabbit sciatic nerve, cDNA cloning, and functional expression","pmids":["2587985"],"confidence":"High","gaps":["Did not define the receptor or signaling pathway","No structural model of the protein"]},{"year":1992,"claim":"Resolved the class of receptor CNTF uses, showing it signals via a shared cytokine receptor component (gp130) rather than a tyrosine kinase receptor like neurotrophins.","evidence":"Tyrosine phosphorylation and gene activation assays comparing CNTF, LIF and IL-6 in neuronal and hematopoietic cell lines","pmids":["1617725"],"confidence":"High","gaps":["Did not yet resolve full receptor subunit composition","Downstream transcription factors unidentified"]},{"year":1993,"claim":"Defined the tripartite receptor architecture and the specificity-determining subunit, showing CNTFRα plus heterodimerized gp130/LIFRβ form the functional complex and that CNTFRα alone confers responsiveness.","evidence":"Receptor reconstitution, co-immunoprecipitation, transfection, and cell-based response assays","pmids":["8390097","8381290"],"confidence":"High","gaps":["Order of subunit assembly not yet established","Cytoplasmic kinases not yet linked"]},{"year":1993,"claim":"Showed CNTFRα is GPI-anchored and can act as a diffusible soluble cofactor, explaining how CNTF responsiveness can be extended beyond cells bearing membrane receptor, including after nerve injury.","evidence":"Cell-based responsiveness assays with soluble CNTFRα, CSF analysis, and muscle denervation model","pmids":["7681218"],"confidence":"High","gaps":["In vivo physiological role of shed receptor not quantified","Stoichiometry not yet defined"]},{"year":1994,"claim":"Connected receptor dimerization to the intracellular signaling machinery, showing gp130/LIFRβ constitutively associate with JAK/TYK kinases activated upon ligand-induced dimerization, and biochemically defined stepwise complex assembly.","evidence":"Co-immunoprecipitation of receptor–kinase complexes, kinase activation assays, biochemical assembly analysis","pmids":["8272873","7852997"],"confidence":"High","gaps":["Cell-type-specific differences in kinase usage not mechanistically explained","STAT specificity not detailed"]},{"year":1994,"claim":"Defined the precise binding stoichiometry of soluble CNTFRα with CNTF, confirming a 1:1 complex that faithfully reconstitutes receptor activity and specificity.","evidence":"Size-exclusion chromatography, gel-shift assay, and TF-1 cell survival assays","pmids":["8180210"],"confidence":"High","gaps":["No crystal structure of the complex","Affinities of subsequent gp130/LIFRβ recruitment not measured here"]},{"year":1994,"claim":"Tested whether CNTF is a non-redundant trophic factor in humans; a common null mutation produces no functional protein yet causes no neurological disease, revealing functional redundancy.","evidence":"Genomic sequencing, minigene transfection, mRNA analysis, and population genotyping","pmids":["8075647"],"confidence":"High","gaps":["Did not identify the redundant ligands","Possible subtle phenotypes not assessed"]},{"year":1995,"claim":"Genetically dissociated CNTFRα from CNTF, showing CNTFRα-null mice die perinatally with motoneuron loss absent in CNTF-null mice, implying an essential second CNTFRα ligand.","evidence":"Comparative phenotyping of CNTF-/- versus CNTFRα-/- knockout mice","pmids":["7585948"],"confidence":"High","gaps":["Identity of the developmental ligand not established here","Mechanism of perinatal lethality unresolved"]},{"year":1995,"claim":"Mapped the CNTFRα-binding surface of CNTF and demonstrated affinity could be engineered, identifying the D-helix/Gln167 as a functional receptor-contact site.","evidence":"Phage display affinity maturation with in vitro binding and cell-based bioactivity assays","pmids":["7621819"],"confidence":"High","gaps":["LIFRβ and gp130 contact sites not yet defined","Structural basis of enhanced affinity not resolved"]},{"year":1996,"claim":"Identified the distinct LIFRβ-binding determinant (F152/K155) on CNTF and exploited it to engineer a competitive receptor antagonist, separating receptor-binding functions.","evidence":"Alanine-scanning mutagenesis with binding and bioactivity assays","pmids":["8799186"],"confidence":"High","gaps":["gp130 contact residues not mapped","Antagonist in vivo efficacy not tested here"]},{"year":1996,"claim":"Uncovered cryptic ligand redundancy in motoneuron support, showing LIF provides trophic support unmasked only when CNTF is also absent.","evidence":"CNTF-/-/LIF-/- double knockout with quantitative motoneuron and grip-strength analysis","pmids":["8793295"],"confidence":"High","gaps":["Did not include all family ligands","Cellular source of compensatory LIF not defined"]},{"year":2000,"claim":"Identified a true second ligand for CNTFRα, the secreted CLF/CLC complex, that activates the same receptor and supports motoneuron survival.","evidence":"Co-secretion assays, STAT3 activation, receptor specificity tests, motoneuron survival assays","pmids":["10966616"],"confidence":"High","gaps":["Whether CLF/CLC is the developmental ligand causing CNTFRα-null lethality not confirmed","In vivo CLC sources not mapped"]},{"year":2000,"claim":"Resolved the kinase responsible for the activating STAT3 Ser727 phosphorylation, showing mTOR rather than MAPK or PKC mediates maximal STAT3 transcriptional output downstream of CNTF.","evidence":"In vitro mTOR kinase assay, rapamycin and pathway inhibitors, dominant-negative mTOR, STAT3 Ser727Ala reporter","pmids":["10660304"],"confidence":"High","gaps":["Cell-context generality not established","Link between receptor activation and mTOR engagement not detailed"]},{"year":2000,"claim":"Identified an obligatory downstream mediator of CNTF motoneuron survival, showing Reg-2 acts as an autocrine/paracrine effector through PI3K-Akt-NF-κB.","evidence":"Antisense adenovirus knockdown and purified Reg-2 survival assays with pathway inhibitors in cultured motoneurons","pmids":["11146655"],"confidence":"High","gaps":["Reg-2 receptor not identified","In vivo requirement of Reg-2 not tested"]},{"year":2002,"claim":"Extended CNTF function to glial maturation, showing it promotes oligodendrocyte myelination via gp130 and JAK.","evidence":"Oligodendrocyte myelination index assays with JAK pathway pharmacological blockade","pmids":["12417647"],"confidence":"Medium","gaps":["Single-lab cell culture study without genetic validation","STAT effector not identified"]},{"year":2003,"claim":"Defined a species difference and receptor-substitution capacity, showing human CNTF can use IL-6Rα in place of CNTFRα but cannot engage gp130/LIFRβ without an alpha receptor.","evidence":"Cell-based signaling and receptor competition assays with chimeric constructs","pmids":["12643274"],"confidence":"Medium","gaps":["Single-lab functional assays","Physiological relevance of IL-6Rα usage unclear"]},{"year":2006,"claim":"Established a peripheral metabolic role, showing CNTF acts directly on skeletal muscle via CNTFRα-IL-6R-gp130 to activate AMPK and reverse insulin resistance independent of the brain.","evidence":"In vivo skeletal muscle AMPK activation and central-versus-peripheral pathway dissection","pmids":["16604088"],"confidence":"High","gaps":["Long-term metabolic effects not addressed here","Endogenous physiological trigger unclear"]},{"year":2007,"claim":"Identified astrocyte-derived CNTF as a key mediator of injury-induced retinal ganglion cell protection and axon growth, acting through STAT3.","evidence":"Intravitreal CNTF neutralization, JAK inhibition, STAT3 immunostaining, and CNTF-/- comparison in vivo","pmids":["17971355"],"confidence":"High","gaps":["Did not separate direct from indirect effects on RGCs","Relative contribution of multiple inflammatory mediators not resolved"]},{"year":2009,"claim":"Demonstrated CNTF uses distinct signaling cascades for different outcomes and amplifies its own expression, with JAK/STAT3 and PI3K/AKT driving RGC axon growth and exogenous CNTF inducing endogenous astrocytic CNTF via MAPK/ERK.","evidence":"In vitro neurite outgrowth with pathway inhibitors, CNTF-/- mice, and MAPK/ERK inhibition in vivo","pmids":["19332123"],"confidence":"High","gaps":["Mechanism coupling receptor to ERK-driven autoinduction not detailed","Quantitative contribution of autoinduction unclear"]},{"year":2009,"claim":"Showed CNTFRα is co-opted by humanin to form a CNTFRα-WSX-1-gp130 neuroprotective receptor, broadening CNTFRα's ligand repertoire.","evidence":"In vitro reconstituted binding, siRNA knockdown, and receptor overexpression protection assays","pmids":["19386761"],"confidence":"Medium","gaps":["Single-lab study on a secondary ligand","In vivo relevance not established"]},{"year":2009,"claim":"Extended CNTF protection to non-neural and lower-vertebrate contexts, showing JAK2/STAT3-dependent islet protection and divergent MAPK-versus-STAT3 use for photoreceptor protection versus Müller glia proliferation.","evidence":"Pharmacological pathway inhibition and morpholino knockdown in rat islets and adult zebrafish retina","pmids":["19272793","19450453"],"confidence":"Medium","gaps":["Single-lab pharmacological studies without genetic confirmation in mammals","Cross-species generality uncertain"]},{"year":2012,"claim":"Identified endogenous CNTF as a driver of injury-induced adult neurogenesis acting through FGF2 induction.","evidence":"CNTF-/- mice, BrdU proliferation, MCAO stroke model, and FGF2/EGF/Notch1 expression analysis","pmids":["22960105"],"confidence":"High","gaps":["Direct versus FGF2-mediated effect not fully separated","Receptor-bearing target cell not defined"]},{"year":2013,"claim":"Defined how CNTF expression is held in check, showing neuronal contact represses astrocytic CNTF via αvβ5 integrin-FAK-JNK signaling and FAK-mediated inhibitory STAT3 Ser727 phosphorylation, with STAT3 binding the CNTF promoter.","evidence":"Integrin antibodies, FAK/JNK inhibitors, co-culture, STAT3 ChIP, and in vivo FAK inhibitor microinjection","pmids":["23693126"],"confidence":"High","gaps":["Interplay between activating and inhibitory STAT3 phosphorylation not fully reconciled","Thy1 receptor partner not defined"]},{"year":2018,"claim":"Revealed a volume-transmission neuroendocrine role, showing CRH-driven CNTF release into the ventricular system activates locus coeruleus norepinephrine synthesis via sequential ERK1 and tyrosine hydroxylase phosphorylation gated by secretagogin.","evidence":"Tract tracing, conditional CNTF/secretagogin ablation, phosphorylation and behavioral assays, human tissue validation","pmids":["30209240"],"confidence":"High","gaps":["Receptor subunits mediating this CNS action not specified","Generality across stress paradigms not exhausted"]},{"year":2020,"claim":"Established CNTF as a propagator of peripheral neuroinflammation and pain, showing Schwann-cell CNTF drives STAT3-dependent IL-6 induction transmitted from periphery to spinal cord.","evidence":"CNTF-/- mice, recombinant CNTF application, pain behavior, STAT3 and IL-6 quantification in DRG and spinal cord","pmids":["32433966"],"confidence":"High","gaps":["Cellular target of CNTF in DRG not fully defined","Therapeutic window not addressed"]},{"year":2021,"claim":"Showed that CNTF's regenerative effect can be largely indirect and immune-mediated, since RGC-specific CNTFRα deletion did not block optic nerve regeneration whereas a CCL5-CCR5 axis engaging immune cells did.","evidence":"Conditional CRISPR CNTFRα/CCR5 knockout, neutrophil/monocyte depletion, recombinant CCL5, and CCR5 antagonist with axon regeneration quantification","pmids":["33627402"],"confidence":"High","gaps":["Relative split between direct and indirect mechanisms not quantified","Cell type releasing CCL5 in response to CNTF not fully resolved"]},{"year":null,"claim":"The molecular identity of the essential developmental CNTFRα ligand responsible for the perinatal lethality of CNTFRα-null mice, and how its signaling differs from CNTF's, remains unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No single ligand has been shown to fully account for the CNTFRα-null phenotype","In vivo deconvolution of CNTF, CLC/CLF and humanin contributions through shared CNTFRα is incomplete"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[0,2,3,8]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[1,5,6]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[10,11]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,4,8]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[2,3,4]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,5,6,14]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[26,27]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[9,12,17,23]}],"complexes":["CNTFRα–gp130–LIFRβ tripartite receptor complex","CNTF–soluble CNTFRα 1:1 ligand complex","CNTFRα–WSX-1–gp130 humanin receptor complex"],"partners":["CNTFR","IL6ST","LIFR","JAK1","STAT3","MTOR","IL6R","CRLF1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P26441","full_name":"Ciliary neurotrophic factor","aliases":[],"length_aa":200,"mass_kda":22.9,"function":"CNTF is a survival factor for various neuronal cell types. Seems to prevent the degeneration of motor axons after axotomy","subcellular_location":"Cytoplasm","url":"https://www.uniprot.org/uniprotkb/P26441/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CNTF","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CNTF","total_profiled":1310},"omim":[{"mim_id":"619289","title":"ZINC FINGER PROTEIN 91, ATYPICAL E3 UBIQUITIN LIGASE; ZFP91","url":"https://www.omim.org/entry/619289"},{"mim_id":"614962","title":"LEPTIN DEFICIENCY OR DYSFUNCTION; LEPD","url":"https://www.omim.org/entry/614962"},{"mim_id":"610313","title":"CRISPONI/COLD-INDUCED SWEATING SYNDROME 2; CISS2","url":"https://www.omim.org/entry/610313"},{"mim_id":"607672","title":"CARDIOTROPHIN-LIKE CYTOKINE FACTOR 1; CLCF1","url":"https://www.omim.org/entry/607672"},{"mim_id":"606386","title":"OLIGODENDROCYTE LINEAGE TRANSCRIPTION FACTOR 2; OLIG2","url":"https://www.omim.org/entry/606386"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"bone marrow","ntpm":6.5},{"tissue":"brain","ntpm":11.6}],"url":"https://www.proteinatlas.org/search/CNTF"},"hgnc":{"alias_symbol":["HCNTF"],"prev_symbol":[]},"alphafold":{"accession":"P26441","domains":[{"cath_id":"1.20.1250.10","chopping":"10-51_66-182","consensus_level":"high","plddt":91.744,"start":10,"end":182}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P26441","model_url":"https://alphafold.ebi.ac.uk/files/AF-P26441-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P26441-F1-predicted_aligned_error_v6.png","plddt_mean":85.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CNTF","jax_strain_url":"https://www.jax.org/strain/search?query=CNTF"},"sequence":{"accession":"P26441","fasta_url":"https://rest.uniprot.org/uniprotkb/P26441.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P26441/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P26441"}},"corpus_meta":[{"pmid":"8272873","id":"PMC_8272873","title":"Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components.","date":"1994","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/8272873","citation_count":929,"is_preprint":false},{"pmid":"1617725","id":"PMC_1617725","title":"CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130.","date":"1992","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/1617725","citation_count":688,"is_preprint":false},{"pmid":"8390097","id":"PMC_8390097","title":"LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor.","date":"1993","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/8390097","citation_count":624,"is_preprint":false},{"pmid":"2587985","id":"PMC_2587985","title":"Purification, cloning, and expression of ciliary neurotrophic factor (CNTF).","date":"1989","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/2587985","citation_count":410,"is_preprint":false},{"pmid":"10660304","id":"PMC_10660304","title":"Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR.","date":"2000","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/10660304","citation_count":407,"is_preprint":false},{"pmid":"8381290","id":"PMC_8381290","title":"The alpha component of the CNTF receptor is required for signaling and defines potential CNTF targets in the adult and during development.","date":"1993","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/8381290","citation_count":397,"is_preprint":false},{"pmid":"7681218","id":"PMC_7681218","title":"Released form of CNTF receptor alpha component as a soluble mediator of CNTF responses.","date":"1993","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/7681218","citation_count":343,"is_preprint":false},{"pmid":"1918150","id":"PMC_1918150","title":"Regional distribution, developmental changes, and cellular localization of CNTF-mRNA and protein in the rat brain.","date":"1991","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/1918150","citation_count":325,"is_preprint":false},{"pmid":"7585948","id":"PMC_7585948","title":"Mice lacking the CNTF receptor, unlike mice lacking CNTF, exhibit profound motor neuron deficits at birth.","date":"1995","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/7585948","citation_count":323,"is_preprint":false},{"pmid":"7472491","id":"PMC_7472491","title":"Injury-induced upregulation of bFGF and CNTF mRNAS in the rat retina.","date":"1995","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/7472491","citation_count":287,"is_preprint":false},{"pmid":"8833452","id":"PMC_8833452","title":"The neurotrophins and CNTF: two families of collaborative neurotrophic factors.","date":"1996","source":"Annual review of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/8833452","citation_count":256,"is_preprint":false},{"pmid":"12356837","id":"PMC_12356837","title":"Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa.","date":"2002","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/12356837","citation_count":250,"is_preprint":false},{"pmid":"16604088","id":"PMC_16604088","title":"CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK.","date":"2006","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16604088","citation_count":236,"is_preprint":false},{"pmid":"16708079","id":"PMC_16708079","title":"AAV-mediated expression of CNTF promotes long-term survival and regeneration of adult rat retinal ganglion cells.","date":"2006","source":"Gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/16708079","citation_count":222,"is_preprint":false},{"pmid":"10966616","id":"PMC_10966616","title":"CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex.","date":"2000","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/10966616","citation_count":220,"is_preprint":false},{"pmid":"7852997","id":"PMC_7852997","title":"The tripartite CNTF receptor complex: activation and signaling involves components shared with other cytokines.","date":"1994","source":"Journal of neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/7852997","citation_count":213,"is_preprint":false},{"pmid":"12417647","id":"PMC_12417647","title":"Ciliary neurotrophic factor (CNTF) enhances myelin formation: a novel role for CNTF and CNTF-related molecules.","date":"2002","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/12417647","citation_count":204,"is_preprint":false},{"pmid":"17971355","id":"PMC_17971355","title":"Astrocyte-derived CNTF switches mature RGCs to a regenerative state following inflammatory stimulation.","date":"2007","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/17971355","citation_count":203,"is_preprint":false},{"pmid":"18063589","id":"PMC_18063589","title":"ROCK inhibition and CNTF interact on intrinsic signalling pathways and differentially regulate survival and regeneration in retinal ganglion cells.","date":"2007","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/18063589","citation_count":200,"is_preprint":false},{"pmid":"19060281","id":"PMC_19060281","title":"Effect of CNTF on retinal ganglion cell survival in experimental glaucoma.","date":"2008","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/19060281","citation_count":185,"is_preprint":false},{"pmid":"11146655","id":"PMC_11146655","title":"Reg-2 is a motoneuron neurotrophic factor and a signalling intermediate in the CNTF survival pathway.","date":"2000","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11146655","citation_count":183,"is_preprint":false},{"pmid":"8075647","id":"PMC_8075647","title":"A null mutation in the human CNTF gene is not causally related to neurological diseases.","date":"1994","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8075647","citation_count":181,"is_preprint":false},{"pmid":"19386761","id":"PMC_19386761","title":"Humanin inhibits neuronal cell death by interacting with a cytokine receptor complex or complexes involving CNTF receptor alpha/WSX-1/gp130.","date":"2009","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/19386761","citation_count":172,"is_preprint":false},{"pmid":"1372570","id":"PMC_1372570","title":"Effects of ciliary neurotrophic factor (CNTF) and depolarization on neuropeptide expression in cultured sympathetic neurons.","date":"1992","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/1372570","citation_count":159,"is_preprint":false},{"pmid":"8793295","id":"PMC_8793295","title":"Cryptic physiological trophic support of motoneurons by LIF revealed by double gene targeting of CNTF and LIF.","date":"1996","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/8793295","citation_count":148,"is_preprint":false},{"pmid":"8756445","id":"PMC_8756445","title":"Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington's disease.","date":"1996","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/8756445","citation_count":147,"is_preprint":false},{"pmid":"19332123","id":"PMC_19332123","title":"Exogenous CNTF stimulates axon regeneration of retinal ganglion cells partially via endogenous CNTF.","date":"2009","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/19332123","citation_count":138,"is_preprint":false},{"pmid":"32433966","id":"PMC_32433966","title":"CNTF-STAT3-IL-6 Axis Mediates Neuroinflammatory Cascade across Schwann Cell-Neuron-Microglia.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32433966","citation_count":130,"is_preprint":false},{"pmid":"9268592","id":"PMC_9268592","title":"Mechanical injury increases bFGF and CNTF mRNA expression in the mouse retina.","date":"1997","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/9268592","citation_count":126,"is_preprint":false},{"pmid":"12643274","id":"PMC_12643274","title":"Signaling of human ciliary neurotrophic factor (CNTF) revisited. The interleukin-6 receptor can serve as an alpha-receptor for CTNF.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12643274","citation_count":122,"is_preprint":false},{"pmid":"1606686","id":"PMC_1606686","title":"The expression of CNTF message and immunoreactivity in the central and peripheral nervous system of the rat.","date":"1992","source":"Brain research. Developmental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/1606686","citation_count":112,"is_preprint":false},{"pmid":"8723221","id":"PMC_8723221","title":"Combined effects of GDNF, BDNF, and CNTF on motoneuron differentiation in vitro.","date":"1996","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/8723221","citation_count":112,"is_preprint":false},{"pmid":"26187860","id":"PMC_26187860","title":"Ciliary neurotrophic factor (CNTF): New facets of an old molecule for treating neurodegenerative and metabolic syndrome pathologies.","date":"2015","source":"Cytokine & growth factor reviews","url":"https://pubmed.ncbi.nlm.nih.gov/26187860","citation_count":111,"is_preprint":false},{"pmid":"1824101","id":"PMC_1824101","title":"Effect of ciliary neurotrophic factor (CNTF) on motoneuron survival.","date":"1991","source":"Journal of cell science. Supplement","url":"https://pubmed.ncbi.nlm.nih.gov/1824101","citation_count":111,"is_preprint":false},{"pmid":"10954906","id":"PMC_10954906","title":"Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF.","date":"2000","source":"Human gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/10954906","citation_count":110,"is_preprint":false},{"pmid":"10860786","id":"PMC_10860786","title":"Adenovirus-mediated expression of ciliary neurotrophic factor (CNTF) rescues axotomized rat retinal ganglion cells but does not support axonal regeneration in vivo.","date":"2000","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/10860786","citation_count":99,"is_preprint":false},{"pmid":"19450453","id":"PMC_19450453","title":"CNTF induces photoreceptor neuroprotection and Müller glial cell proliferation through two different signaling pathways in the adult zebrafish retina.","date":"2009","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/19450453","citation_count":98,"is_preprint":false},{"pmid":"9217144","id":"PMC_9217144","title":"Simultaneous treatment with BDNF and CNTF after peripheral nerve transection and repair enhances rate of functional recovery compared with BDNF treatment alone.","date":"1997","source":"The Laryngoscope","url":"https://pubmed.ncbi.nlm.nih.gov/9217144","citation_count":95,"is_preprint":false},{"pmid":"11311041","id":"PMC_11311041","title":"Cellular and subcellular patterns of expression of bFGF and CNTF in the normal and light stressed adult rat retina.","date":"2001","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/11311041","citation_count":91,"is_preprint":false},{"pmid":"8860837","id":"PMC_8860837","title":"Gene therapy for amyotrophic lateral sclerosis (ALS) using a polymer encapsulated xenogenic cell line engineered to secrete hCNTF.","date":"1996","source":"Human gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/8860837","citation_count":89,"is_preprint":false},{"pmid":"16872907","id":"PMC_16872907","title":"In contrast to AAV-mediated Cntf expression, AAV-mediated Gdnf expression enhances gene replacement therapy in rodent models of retinal degeneration.","date":"2006","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/16872907","citation_count":83,"is_preprint":false},{"pmid":"12828933","id":"PMC_12828933","title":"Astrocytes produce CNTF during the remyelination phase of viral-induced spinal cord demyelination to stimulate FGF-2 production.","date":"2003","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/12828933","citation_count":81,"is_preprint":false},{"pmid":"15634701","id":"PMC_15634701","title":"CNTF/LIF/gp130 receptor complex signaling maintains a VZ precursor differentiation gradient in the developing ventral forebrain.","date":"2005","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15634701","citation_count":78,"is_preprint":false},{"pmid":"17156753","id":"PMC_17156753","title":"CNTF+BDNF treatment and neuroprotective pathways in the rd1 mouse retina.","date":"2006","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/17156753","citation_count":77,"is_preprint":false},{"pmid":"15555930","id":"PMC_15555930","title":"BMP4 and CNTF are neuroprotective and suppress damage-induced proliferation of Müller glia in the retina.","date":"2004","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/15555930","citation_count":69,"is_preprint":false},{"pmid":"11890844","id":"PMC_11890844","title":"Association of a null mutation in the CNTF gene with early onset of multiple sclerosis.","date":"2002","source":"Archives of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/11890844","citation_count":69,"is_preprint":false},{"pmid":"9171158","id":"PMC_9171158","title":"Cellular delivery of human CNTF prevents motor and cognitive dysfunction in a rodent model of Huntington's disease.","date":"1997","source":"Cell transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/9171158","citation_count":68,"is_preprint":false},{"pmid":"22960105","id":"PMC_22960105","title":"Endogenous CNTF mediates stroke-induced adult CNS neurogenesis in mice.","date":"2012","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/22960105","citation_count":68,"is_preprint":false},{"pmid":"9617544","id":"PMC_9617544","title":"Continuous exposure to bright light upregulates bFGF and CNTF expression in the rat retina.","date":"1998","source":"Current eye research","url":"https://pubmed.ncbi.nlm.nih.gov/9617544","citation_count":68,"is_preprint":false},{"pmid":"12645079","id":"PMC_12645079","title":"Adenoviral gene transfer of GDNF, BDNF and TGF beta 2, but not CNTF, cardiotrophin-1 or IGF1, protects injured adult motoneurons after facial nerve avulsion.","date":"2003","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/12645079","citation_count":65,"is_preprint":false},{"pmid":"25896245","id":"PMC_25896245","title":"CNTF Gene Therapy Confers Lifelong Neuroprotection in a Mouse Model of Human Retinitis Pigmentosa.","date":"2015","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/25896245","citation_count":64,"is_preprint":false},{"pmid":"17898009","id":"PMC_17898009","title":"Activation of the ciliary neurotrophic factor (CNTF) signalling pathway in cortical neurons of multiple sclerosis patients.","date":"2007","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/17898009","citation_count":64,"is_preprint":false},{"pmid":"15716414","id":"PMC_15716414","title":"Triple knock-out of CNTF, LIF, and CT-1 defines cooperative and distinct roles of these neurotrophic factors for motoneuron maintenance and function.","date":"2005","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15716414","citation_count":62,"is_preprint":false},{"pmid":"11870876","id":"PMC_11870876","title":"CNTF and CNTF receptor alpha are constitutively expressed by astrocytes in the mouse brain.","date":"2002","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/11870876","citation_count":61,"is_preprint":false},{"pmid":"9788278","id":"PMC_9788278","title":"Oligodendroglial survival factors, PDGF-AA and CNTF, activate similar JAK/STAT signaling pathways.","date":"1998","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/9788278","citation_count":61,"is_preprint":false},{"pmid":"15790921","id":"PMC_15790921","title":"CNTF and BDNF have similar effects on retinal ganglion cell survival but differential effects on nitric oxide synthase expression soon after optic nerve injury.","date":"2005","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/15790921","citation_count":61,"is_preprint":false},{"pmid":"33627402","id":"PMC_33627402","title":"Chemokine CCL5 promotes robust optic nerve regeneration and mediates many of the effects of CNTF gene therapy.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/33627402","citation_count":60,"is_preprint":false},{"pmid":"1319503","id":"PMC_1319503","title":"Peripheral nerve injury down-regulates CNTF expression in adult rat sciatic nerves.","date":"1992","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/1319503","citation_count":57,"is_preprint":false},{"pmid":"24727569","id":"PMC_24727569","title":"Combined suppression of CASP2 and CASP6 protects retinal ganglion cells from apoptosis and promotes axon regeneration through CNTF-mediated JAK/STAT signalling.","date":"2014","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/24727569","citation_count":57,"is_preprint":false},{"pmid":"7621819","id":"PMC_7621819","title":"CNTF variants with increased biological potency and receptor selectivity define a functional site of receptor interaction.","date":"1995","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/7621819","citation_count":56,"is_preprint":false},{"pmid":"10590179","id":"PMC_10590179","title":"Expression of CNTF/LIF-receptor components and activation of STAT3 signaling in axotomized facial motoneurons: evidence for a sequential postlesional function of the cytokines.","date":"1999","source":"Journal of neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/10590179","citation_count":52,"is_preprint":false},{"pmid":"9073449","id":"PMC_9073449","title":"CNTF and LIF are not required for the target-directed acquisition of cholinergic and peptidergic properties by sympathetic neurons in vivo.","date":"1997","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/9073449","citation_count":52,"is_preprint":false},{"pmid":"8799186","id":"PMC_8799186","title":"Identification of ciliary neurotrophic factor (CNTF) residues essential for leukemia inhibitory factor receptor binding and generation of CNTF receptor antagonists.","date":"1996","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8799186","citation_count":52,"is_preprint":false},{"pmid":"24721701","id":"PMC_24721701","title":"Myokines (muscle-derived cytokines and chemokines) including ciliary neurotrophic factor (CNTF) inhibit osteoblast differentiation.","date":"2014","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/24721701","citation_count":51,"is_preprint":false},{"pmid":"28017835","id":"PMC_28017835","title":"AAV-mediated transfer of RhoA shRNA and CNTF promotes retinal ganglion cell survival and axon regeneration.","date":"2016","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28017835","citation_count":49,"is_preprint":false},{"pmid":"21912637","id":"PMC_21912637","title":"CNTF mediates neurotrophic factor secretion and fluid absorption in human retinal pigment epithelium.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21912637","citation_count":46,"is_preprint":false},{"pmid":"15572170","id":"PMC_15572170","title":"CNTF, a pleiotropic cytokine: emphasis on its myotrophic role.","date":"2004","source":"Brain research. Brain research reviews","url":"https://pubmed.ncbi.nlm.nih.gov/15572170","citation_count":46,"is_preprint":false},{"pmid":"9058319","id":"PMC_9058319","title":"Changes in expression of ciliary neurotrophic factor (CNTF) and CNTF-receptor alpha after spinal cord injury.","date":"1997","source":"Journal of neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/9058319","citation_count":46,"is_preprint":false},{"pmid":"11303750","id":"PMC_11303750","title":"IL-6 up-regulates CNTF mRNA expression and enhances neurite regeneration.","date":"2001","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/11303750","citation_count":45,"is_preprint":false},{"pmid":"8980880","id":"PMC_8980880","title":"Physiological effects of CNTF-induced wasting.","date":"1996","source":"Cytokine","url":"https://pubmed.ncbi.nlm.nih.gov/8980880","citation_count":45,"is_preprint":false},{"pmid":"11095633","id":"PMC_11095633","title":"Green cone opsin and rhodopsin regulation by CNTF and staurosporine in cultured chick photoreceptors.","date":"2000","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/11095633","citation_count":41,"is_preprint":false},{"pmid":"9645962","id":"PMC_9645962","title":"Differential regulation of ciliary neurotrophic factor (CNTF) and CNTF receptor alpha (CNTFR alpha) expression following focal cerebral ischemia.","date":"1998","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/9645962","citation_count":41,"is_preprint":false},{"pmid":"8384037","id":"PMC_8384037","title":"The molecular biology of the CNTF receptor.","date":"1993","source":"Current opinion in neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/8384037","citation_count":40,"is_preprint":false},{"pmid":"8294148","id":"PMC_8294148","title":"Rat ciliary neurotrophic factor (CNTF): gene structure and regulation of mRNA levels in glial cell cultures.","date":"1993","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/8294148","citation_count":40,"is_preprint":false},{"pmid":"9075806","id":"PMC_9075806","title":"Aldose reductase inhibition increases CNTF-like bioactivity and protein in sciatic nerves from galactose-fed and normal rats.","date":"1997","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/9075806","citation_count":40,"is_preprint":false},{"pmid":"8866127","id":"PMC_8866127","title":"Therapeutic potential of the neurotrophins and neurotrophin-CNTF combinations in peripheral neuropathies and motor neuron diseases.","date":"1996","source":"Ciba Foundation symposium","url":"https://pubmed.ncbi.nlm.nih.gov/8866127","citation_count":37,"is_preprint":false},{"pmid":"16831422","id":"PMC_16831422","title":"CNTF gene transfer protects ganglion cells in rat retinae undergoing focal injury and branch vessel occlusion.","date":"2006","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/16831422","citation_count":36,"is_preprint":false},{"pmid":"16143329","id":"PMC_16143329","title":"CNTF induces dose-dependent alterations in retinal morphology in normal and rcd-1 canine retina.","date":"2005","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/16143329","citation_count":36,"is_preprint":false},{"pmid":"19272793","id":"PMC_19272793","title":"Ciliary neurotrophic factor (CNTF) signals through STAT3-SOCS3 pathway and protects rat pancreatic islets from cytokine-induced apoptosis.","date":"2009","source":"Cytokine","url":"https://pubmed.ncbi.nlm.nih.gov/19272793","citation_count":35,"is_preprint":false},{"pmid":"30237104","id":"PMC_30237104","title":"Pronounced synergistic neuroprotective effect of GDNF and CNTF on axotomized retinal ganglion cells in the adult mouse.","date":"2018","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/30237104","citation_count":34,"is_preprint":false},{"pmid":"1666130","id":"PMC_1666130","title":"Effect of CNTF on low-affinity NGF receptor expression by cultured neurons from different rat brain regions.","date":"1991","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/1666130","citation_count":34,"is_preprint":false},{"pmid":"20494870","id":"PMC_20494870","title":"Synergistic effects of NGF, CNTF and GDNF on functional recovery following sciatic nerve injury in rats.","date":"2010","source":"Advances in medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/20494870","citation_count":34,"is_preprint":false},{"pmid":"9737548","id":"PMC_9737548","title":"Increased expression of CNTF receptor alpha in denervated human skeletal muscle.","date":"1998","source":"Journal of neuropathology and experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/9737548","citation_count":33,"is_preprint":false},{"pmid":"23693126","id":"PMC_23693126","title":"Inhibition of a novel specific neuroglial integrin signaling pathway increases STAT3-mediated CNTF expression.","date":"2013","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/23693126","citation_count":33,"is_preprint":false},{"pmid":"22349107","id":"PMC_22349107","title":"Ciliary neurotrophic factor (CNTF) protects non-obese Swiss mice against type 2 diabetes by increasing beta cell mass and reducing insulin clearance.","date":"2012","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/22349107","citation_count":33,"is_preprint":false},{"pmid":"30209240","id":"PMC_30209240","title":"Hypothalamic CNTF volume transmission shapes cortical noradrenergic excitability upon acute stress.","date":"2018","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/30209240","citation_count":32,"is_preprint":false},{"pmid":"12935781","id":"PMC_12935781","title":"Anti-apoptotic effects of CNTF gene transfer on photoreceptor degeneration in experimental antibody-induced retinopathy.","date":"2003","source":"Journal of autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/12935781","citation_count":31,"is_preprint":false},{"pmid":"12543126","id":"PMC_12543126","title":"Molecular cloning and characterisation of a carp (Cyprinus carpio) cytokine-like cDNA that shares sequence similarity with IL-6 subfamily cytokines CNTF, OSM and LIF.","date":"2003","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12543126","citation_count":31,"is_preprint":false},{"pmid":"8884748","id":"PMC_8884748","title":"Activating mechanism of CNTF and related cytokines.","date":"1996","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/8884748","citation_count":30,"is_preprint":false},{"pmid":"17272411","id":"PMC_17272411","title":"Polymorphisms in the CNTF and CNTF receptor genes are associated with muscle strength in men and women.","date":"2007","source":"Journal of applied physiology (Bethesda, Md. : 1985)","url":"https://pubmed.ncbi.nlm.nih.gov/17272411","citation_count":30,"is_preprint":false},{"pmid":"15949503","id":"PMC_15949503","title":"Mechanisms of axonal degeneration in EAE--lessons from CNTF and MHC I knockout mice.","date":"2005","source":"Journal of the neurological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/15949503","citation_count":29,"is_preprint":false},{"pmid":"8180210","id":"PMC_8180210","title":"Recombinant human CNTF receptor alpha: production, binding stoichiometry, and characterization of its activity as a diffusible factor.","date":"1994","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8180210","citation_count":29,"is_preprint":false},{"pmid":"9694834","id":"PMC_9694834","title":"A bidirectional regulation between the TR2/TR4 orphan receptors (TR2/TR4) and the ciliary neurotrophic factor (CNTF) signaling pathway.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9694834","citation_count":29,"is_preprint":false},{"pmid":"9051264","id":"PMC_9051264","title":"CNTF induces GFAP in a S-100 alpha brain cell population: the pattern of CNTF-alpha R suggests an indirect mode of action.","date":"1997","source":"Brain research. Developmental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/9051264","citation_count":29,"is_preprint":false},{"pmid":"25698661","id":"PMC_25698661","title":"The MAPK and PI3K pathways mediate CNTF-induced neuronal survival and process outgrowth in hypothalamic organotypic cultures.","date":"2015","source":"Journal of cell communication and signaling","url":"https://pubmed.ncbi.nlm.nih.gov/25698661","citation_count":28,"is_preprint":false},{"pmid":"16475952","id":"PMC_16475952","title":"Intracompartmental delivery of CNTF as therapy for Huntington's disease and retinitis pigmentosa.","date":"2006","source":"Current gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/16475952","citation_count":27,"is_preprint":false},{"pmid":"1818108","id":"PMC_1818108","title":"The neurotrophins and CNTF: specificity of action towards PNS and CNS neurons.","date":"1991","source":"Journal de physiologie","url":"https://pubmed.ncbi.nlm.nih.gov/1818108","citation_count":26,"is_preprint":false},{"pmid":"23845766","id":"PMC_23845766","title":"Low level methylmercury enhances CNTF-evoked STAT3 signaling and glial differentiation in cultured cortical progenitor cells.","date":"2013","source":"Neurotoxicology","url":"https://pubmed.ncbi.nlm.nih.gov/23845766","citation_count":26,"is_preprint":false},{"pmid":"32932933","id":"PMC_32932933","title":"Intravitreal Co-Administration of GDNF and CNTF Confers Synergistic and Long-Lasting Protection against Injury-Induced Cell Death of Retinal Ganglion Cells in Mice.","date":"2020","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/32932933","citation_count":25,"is_preprint":false},{"pmid":"8543936","id":"PMC_8543936","title":"Investigation of a null mutation of the CNTF gene in familial amyotrophic lateral sclerosis.","date":"1995","source":"Journal of the neurological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/8543936","citation_count":25,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49786,"output_tokens":7430,"usd":0.130404,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16870,"output_tokens":7204,"usd":0.132225,"stage2_stop_reason":"end_turn"},"total_usd":0.262629,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1989,\n      \"finding\": \"CNTF was purified from rabbit sciatic nerve and cloned; biologically active CNTF was expressed from a cDNA clone, establishing it as a distinct neural effector protein with no significant sequence homology to previously known proteins including NGF.\",\n      \"method\": \"Protein purification, cDNA cloning, transient expression assay\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct biochemical purification, cloning, and functional expression in a foundational paper replicated extensively\",\n      \"pmids\": [\"2587985\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"CNTF and LIF share signaling pathways in neuronal cells that involve the IL-6 signal transducing receptor component gp130; CNTF induces the same tyrosine phosphorylations and gene activations as LIF and IL-6 in hematopoietic cells, demonstrating that CNTF signals via a cytokine-type receptor rather than a receptor tyrosine kinase.\",\n      \"method\": \"Tyrosine phosphorylation assays, gene activation assays, receptor component characterization in neuronal and hematopoietic cell lines\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (phosphorylation, gene activation, receptor characterization), replicated by subsequent studies\",\n      \"pmids\": [\"1617725\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"The CNTF receptor complex is tripartite, consisting of the CNTF-specific binding protein CNTFRα plus LIFR-β and gp130; CNTF and LIF both trigger association of initially separate receptor components leading to tyrosine phosphorylation of receptor subunits; signaling requires heterodimerization of gp130 with LIFRβ (unlike IL-6 which uses gp130 homodimerization).\",\n      \"method\": \"Receptor reconstitution, co-immunoprecipitation, tyrosine phosphorylation assays, cell-based signaling assays\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — reconstitution of receptor complex, reciprocal functional assays, replicated across multiple labs\",\n      \"pmids\": [\"8390097\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"CNTFRα is a required receptor component that confers CNTF responsiveness; transfection of CNTFRα into hematopoietic cells normally responsive only to LIF was sufficient to render them CNTF-responsive, demonstrating CNTFRα is necessary and sufficient for CNTF target cell specification.\",\n      \"method\": \"Gene transfection, cell-based CNTF response assay, immunolocalization\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — gain-of-function transfection experiment with clear cellular readout, replicated conceptually across studies\",\n      \"pmids\": [\"8381290\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"CNTFRα is anchored by a GPI linkage and can be released as a soluble form; soluble CNTFRα can function as part of a heterodimeric ligand with CNTF to activate cells lacking membrane-bound CNTFRα, and is present in cerebrospinal fluid and released from skeletal muscle upon peripheral nerve injury.\",\n      \"method\": \"Cell-based responsiveness assays with soluble CNTFRα, CSF analysis, muscle denervation model\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — functional reconstitution with soluble receptor, multiple cell line validations, in vivo detection\",\n      \"pmids\": [\"7681218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"The beta receptor components gp130 and LIFRβ constitutively associate with Jak/Tyk family cytoplasmic tyrosine kinases; ligand-induced dimerization of these receptor beta components activates the kinases; CNTF receptor utilizes all known members of the Jak/Tyk family but induces distinct phosphorylation patterns in different cell lines.\",\n      \"method\": \"Co-immunoprecipitation of receptor–kinase complexes, tyrosine phosphorylation assays, kinase activation assays\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP demonstrating constitutive association, activation by ligand-induced dimerization, replicated\",\n      \"pmids\": [\"8272873\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"CNTF assembles its tripartite receptor in a stepwise fashion: CNTF first binds CNTFRα, then recruits gp130, and finally complexes with LIFRβ; heterodimerization of the beta components activates JAK/TYK kinases that are preassociated with beta components in an inactive state, which in turn activate STAT family transcription factors.\",\n      \"method\": \"Biochemical receptor assembly assays, kinase activation analysis, signaling pathway characterization\",\n      \"journal\": \"Journal of neurobiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — mechanistic dissection of stepwise receptor assembly and downstream kinase-STAT pathway, consistent with multiple independent studies\",\n      \"pmids\": [\"7852997\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Human CNTF null mutation (G to A transition creating a new splice acceptor site) produces only aberrant mRNA and no functional protein; 2.3% of Japanese individuals are homozygous for this mutation, but CNTF deficiency is not causally related to neurological diseases.\",\n      \"method\": \"Genomic sequencing, minigene transfection into cultured cells, mRNA analysis, population genotyping\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — minigene transfection demonstrating exclusive mutant mRNA expression, large population study; negative finding for disease causation is robust\",\n      \"pmids\": [\"8075647\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Recombinant soluble CNTFRα forms a 1:1 stoichiometric complex with CNTF; soluble CNTFRα reconstitutes active complexes on the surface of cells lacking membrane CNTFRα with the same relative ligand specificity and affinity as the cell-surface receptor.\",\n      \"method\": \"Size-exclusion chromatography, protein gel-shift assay, cell-based survival assays with TF-1 cells\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — quantitative biochemical reconstitution with defined stoichiometry and functional validation\",\n      \"pmids\": [\"8180210\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Mice lacking CNTFRα die perinatally with severe motor neuron deficits, whereas mice lacking CNTF itself have no notable developmental neurological abnormalities, demonstrating that CNTFRα serves as receptor for a second developmentally important CNTF-like ligand distinct from CNTF.\",\n      \"method\": \"Gene knockout (null mutation), comparative phenotypic analysis of CNTF-/- vs CNTFRα-/- mice\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct comparison of two knockout models with clear phenotypic divergence, establishing CNTFRα's role beyond CNTF signaling\",\n      \"pmids\": [\"7585948\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"The D-helix region of CNTF (particularly Gln167) is important for CNTFRα binding; phage display-selected variants with substitutions at Gln167 showed greatly increased CNTFRα affinity and enhanced neurotrophic activity via CNTFRα, but did not potentiate CNTFRα-independent receptor actions, demonstrating this region is a functional site for CNTFRα interaction.\",\n      \"method\": \"Phage display affinity maturation, in vitro binding assays, cell-based biological activity assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis combined with phage display selection and functional validation in cell-based assays\",\n      \"pmids\": [\"7621819\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Residues F152 and K155 in the D1 motif of human CNTF are essential for interaction with LIFRβ; alanine substitution of either residue specifically inhibited CNTF interaction with LIFR without affecting binding to CNTFRα or gp130; combined F152A/K155A substitution abolished biological activity; combining these with CNTFRα-affinity enhancing mutations in the D-helix generated a potent competitive CNTF receptor antagonist.\",\n      \"method\": \"Alanine-scanning mutagenesis, in vitro binding assays, cell-based bioactivity assays\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — systematic alanine mutagenesis with orthogonal binding and functional readouts identifying distinct receptor-binding sites\",\n      \"pmids\": [\"8799186\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Simultaneous inactivation of both CNTF and LIF genes in mice produces more extensive and earlier-appearing motoneuron degeneration than CNTF knockout alone, accompanied by reduced grip strength, revealing cryptic physiological trophic support by LIF for motoneurons that is unmasked only when CNTF is also absent.\",\n      \"method\": \"Double gene knockout (CNTF-/- / LIF-/-), quantitative motoneuron analysis, functional grip strength testing\",\n      \"journal\": \"Current biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis via double knockout with quantitative cellular and functional readouts\",\n      \"pmids\": [\"8793295\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"CLC (cardiotrophin-like cytokine) forms a stable secreted heteromeric complex with the soluble receptor CLF; CLF expression is required for CLC secretion; the CLF/CLC complex acts only on cells expressing functional CNTF receptors, activates gp130, LIFRβ, and STAT3, and supports motor neuron survival, identifying it as a second ligand for CNTFRα.\",\n      \"method\": \"Co-expression/secretion assays, cell-based signaling assays (STAT3 activation), motor neuron survival assays, receptor specificity tests\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods demonstrating complex formation, receptor specificity, and functional consequences\",\n      \"pmids\": [\"10966616\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"CNTF-induced serine phosphorylation of STAT3 at Ser727 (required for maximal STAT3 transcriptional activation) is mediated by mTOR, not by MAPK or PKC; mTOR directly phosphorylated a STAT3 Ser727 peptide in a CNTF-dependent manner, and kinase-inactive mTOR mutant failed to do so; rapamycin inhibited this phosphorylation and a STAT3 Ser727Ala mutant reduced reporter activation equivalently.\",\n      \"method\": \"In vitro kinase assay with mTOR, pharmacological inhibition (rapamycin, MAPK inhibitors, PKC inhibitors), dominant-negative mTOR mutant, STAT3 reporter assay with Ser727Ala mutant\",\n      \"journal\": \"Current biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with mutagenesis and pharmacological validation, mechanistically rigorous single study\",\n      \"pmids\": [\"10660304\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Reg-2/PAP I is induced by CNTF-related cytokines in motoneurons and functions as an obligatory intermediate in the CNTF survival signaling pathway; blocking Reg-2 expression via antisense adenovirus specifically abrogated the survival effect of CNTF on cultured motoneurons; Reg-2 itself acts as an autocrine/paracrine neurotrophic factor via PI3K-Akt-NF-κB signaling.\",\n      \"method\": \"Antisense adenovirus knockdown, cultured motoneuron survival assay, purified Reg-2 survival assay, pathway inhibitor studies (PI3K, Akt, NF-κB)\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function knockdown with specific survival readout and pathway characterization\",\n      \"pmids\": [\"11146655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Human CNTF can use both membrane-bound and soluble human IL-6Rα as a substitute for its cognate CNTFRα to widen its target cell spectrum; unlike rat CNTF, human CNTF cannot directly induce a heterodimer of human gp130 and LIFRβ in the absence of an alpha receptor.\",\n      \"method\": \"Cell-based signaling assays, receptor competition assays, chimeric receptor constructs\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — cell-based functional assays, single lab study\",\n      \"pmids\": [\"12643274\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Triple knockout of CNTF, LIF, and CT-1 in mice reveals cooperative but distinct roles: LIF deficiency leads to pronounced loss of distal axons and motor endplate alterations, whereas CNTF and CT-1 deficiency does not cause significant changes in these structures; triple knockout mice show increased motoneuron cell loss correlating with early postnatal muscle weakness.\",\n      \"method\": \"Triple and combined double knockout mouse models, quantitative motoneuron counting, morphological analysis of axons and motor endplates, grip strength testing\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic multi-gene knockout with quantitative cellular and functional readouts distinguishing individual ligand contributions\",\n      \"pmids\": [\"15716414\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"CNTF reverses obesity-induced insulin resistance by signaling through the CNTFRα-IL-6R-gp130β receptor complex in skeletal muscle to activate AMPK, increase fatty-acid oxidation, and reduce insulin resistance independent of central (brain) signaling.\",\n      \"method\": \"In vivo skeletal muscle AMPK activation assays, receptor complex characterization, peripheral (skeletal muscle-specific) vs. central pathway dissection\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined receptor complex, AMPK activation assay in skeletal muscle, brain-independent mechanism demonstrated\",\n      \"pmids\": [\"16604088\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Astrocyte-derived CNTF is a major mediator of the neuroprotective and axon-growth-promoting effects of lens injury (intraocular inflammation) on retinal ganglion cells; CNTF from retinal astrocytes activates STAT3 in RGCs; antibody neutralization of CNTF or JAK inhibition compromised the beneficial effects of lens injury, while anti-oncomodulin was ineffective.\",\n      \"method\": \"Intravitreal antibody neutralization, JAK inhibitor treatment, in vivo RGC regeneration assay, STAT3 phosphorylation immunostaining, CNTF-/- mouse comparison\",\n      \"journal\": \"Brain\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple loss-of-function approaches (antibody, pharmacological inhibitor) with specific cellular readouts in vivo\",\n      \"pmids\": [\"17971355\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Humanin (HN) protects neurons by binding to a receptor complex involving CNTFRα, WSX-1, and gp130; HN induces hetero-oligomerization of these three subunits in vitro; siRNA knockdown of CNTFRα or WSX-1 reduced HN binding and abolished neuroprotection, while overexpression of CNTFRα and/or WSX-1 upregulated HN binding.\",\n      \"method\": \"In vitro reconstituted binding assay, siRNA knockdown, receptor overexpression, loss-of-function cell-based protection assay\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — in vitro reconstitution plus siRNA knockdown, single lab study on a secondary ligand (HN) using CNTFRα\",\n      \"pmids\": [\"19386761\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Exogenous CNTF stimulates RGC axon outgrowth in vitro via JAK/STAT3 and PI3K/AKT signaling pathways; in vivo, exogenously applied CNTF induces endogenous CNTF expression in astrocytes via MAPK/ERK pathway activation; reduction of endogenous CNTF or its absence in CNTF-/- mice markedly reduces the neurite growth-promoting effects of exogenous CNTF.\",\n      \"method\": \"In vitro neurite outgrowth assay with pathway inhibitors, in vivo CNTF-/- mice, MAPK/ERK pathway inhibitors in vivo, endogenous CNTF mRNA quantification\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic (CNTF-/- mice) and pharmacological loss-of-function with in vitro and in vivo readouts, mechanistic pathway identification\",\n      \"pmids\": [\"19332123\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CNTF signals through JAK2/STAT3 cascade in pancreatic islets, increases SOCS3 expression, and protects neonatal rat islets from cytokine-induced apoptosis; these effects were blocked by JAK inhibitor AG490 and STAT3 inhibitor curcumin but not by MAPK or PI3K inhibitors.\",\n      \"method\": \"Pharmacological pathway inhibitors, Western blot for STAT3/Akt/ERK phosphorylation, RT-PCR for SOCS3, apoptosis assays\",\n      \"journal\": \"Cytokine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — pharmacological inhibition with Western blot readouts, single lab, no genetic validation\",\n      \"pmids\": [\"19272793\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Endogenous CNTF mediates stroke-induced neurogenesis in the adult mouse SVZ; CNTF-/- mice lack stroke-induced SVZ proliferation; CNTF appears to act on C cell proliferation and by inducing FGF2 expression but not via EGF or Notch1 signaling.\",\n      \"method\": \"CNTF-/- mice, BrdU proliferation assay, middle cerebral artery occlusion model, FGF2/EGF/Notch1 expression analysis\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockout with specific cellular readout and downstream pathway characterization\",\n      \"pmids\": [\"22960105\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CNTF expression in astrocytes is repressed by neuronal contact via an αvβ5 integrin–FAK–JNK signaling pathway; FAK phosphorylates STAT3 on inhibitory Ser-727 to interfere with pro-transcriptional Tyr-705 activity; blockade of FAK or JNK rapidly induces CNTF mRNA and protein; neuronal surface protein Thy1 acts as a neuroglial CNTF repressor; STAT3 binds the CNTF promoter and mediates FAK antagonist-induced CNTF expression.\",\n      \"method\": \"Integrin-specific antibodies, FAK/JNK/ERK/p38 inhibitors, co-culture experiments, STAT3 chromatin immunoprecipitation, microinjection of FAK inhibitor in vivo, neurogenesis assay\",\n      \"journal\": \"Cell communication and signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal approaches (antibody, pharmacological, ChIP, in vivo injection) in a single mechanistic study\",\n      \"pmids\": [\"23693126\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Hypothalamic CRH neurons innervate ependymal cells of the 3rd ventricle to induce CNTF release; CNTF is transported through the brain's aqueductal system (volume transmission) and binds receptors on locus coeruleus norepinephrinergic neurons; CNTF then initiates sequential phosphorylation of ERK1 and tyrosine hydroxylase (gated by the Ca2+-sensor secretagogin); both CNTF and secretagogin ablation blocked stress-induced cortical norepinephrine synthesis and associated behavioral responses.\",\n      \"method\": \"Neuroanatomical tract tracing, CNTF and secretagogin conditional knockout/ablation, phosphorylation assays (ERK1, tyrosine hydroxylase), behavioral assays, human brain tissue validation\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic ablation models combined with biochemical phosphorylation assays, in vivo pathway and behavioral readouts, validated in human brain\",\n      \"pmids\": [\"30209240\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CNTF from Schwann cells mediates neuroinflammation in sensory neurons via STAT3 activation and consequent IL-6 induction, propagating the inflammatory cascade from the periphery to the spinal cord; CNTF deficiency attenuates neuroinflammation in DRG and spinal cord with reduced pain; recombinant CNTF applied to sensory nerves recapitulates this neuroinflammatory cascade.\",\n      \"method\": \"CNTF-/- mice, recombinant CNTF application, pain behavioral assays, STAT3 phosphorylation assays, IL-6 quantification in DRG and spinal cord\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockout combined with gain-of-function (recombinant CNTF) and mechanistic signaling readouts (STAT3, IL-6)\",\n      \"pmids\": [\"32433966\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CNTF gene therapy promotes optic nerve regeneration partially indirectly through immune mediators: deletion of CNTFRα specifically in RGCs did not diminish the regeneration-promoting effect of CNTF gene therapy, but neutrophil depletion or suppression of monocyte infiltration did; CNTF gene therapy increased CCL5 expression in immune cells and retinal glia, and CCL5 acting through CCR5 on RGCs mediates much of the regenerative effect.\",\n      \"method\": \"Conditional CNTFRα knockout in RGCs (CRISPR), neutrophil depletion, monocyte infiltration suppression, recombinant CCL5 injection, CRISPR CCR5 knockdown in RGCs, CCR5 antagonist treatment, axon regeneration quantification\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic and pharmacological loss-of-function approaches with specific mechanistic readouts, convergent evidence identifying indirect CCL5-CCR5 pathway\",\n      \"pmids\": [\"33627402\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"CNTF enhances myelination by acting on oligodendrocytes to favor their final maturation; this promyelinating effect is mediated through the gp130 receptor common to the CNTF family and transduced through the JAK kinase pathway.\",\n      \"method\": \"Enzymatic myelination index assay, receptor pathway pharmacological blockade (JAK inhibitor), oligodendrocyte culture assays\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — cell culture assay with pharmacological pathway inhibition, single lab\",\n      \"pmids\": [\"12417647\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"In adult zebrafish retina, CNTF utilizes a MAPK-dependent signaling pathway (not Stat3 or Akt) for neuroprotection of light-induced photoreceptor cell death, while it uses a Stat3-dependent pathway (not MAPK or Akt) to stimulate Müller glia proliferation; these two CNTF-mediated processes use distinct intracellular signaling cascades.\",\n      \"method\": \"Intraocular injection, pathway-specific inhibitors (MAPK, Stat3, Akt), Stat3 morpholino knockdown, light-damage model, cell proliferation quantification\",\n      \"journal\": \"Experimental eye research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — pharmacological inhibition and morpholino knockdown in vivo, single lab, zebrafish model\",\n      \"pmids\": [\"19450453\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CNTF is a secreted cytokine (expressed primarily by Schwann cells and astrocytes) that assembles a tripartite receptor complex by sequentially binding GPI-anchored CNTFRα, then recruiting gp130 and LIFRβ; heterodimerization of the beta-receptor components activates preassociated JAK/TYK kinases, which phosphorylate STAT3 (at Tyr705 via JAKs and at Ser727 via mTOR) and activate MAPK and PI3K-AKT pathways to promote neuronal survival, axon regeneration, oligodendrocyte myelination, and skeletal muscle AMPK activation; soluble CNTFRα can act as a diffusible cofactor to extend CNTF responsiveness to cells lacking membrane-bound CNTFRα; in vivo, CNTF can also act indirectly by inducing downstream mediators such as Reg-2 in motoneurons, CCL5 in retinal immune/glial cells, and FGF2 in astrocytes, and hypothalamic CNTF volume transmission links stress-induced CRH signaling to locus coeruleus norepinephrine synthesis via sequential ERK1 and tyrosine hydroxylase phosphorylation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CNTF is a secreted neural cytokine, originally purified from sciatic nerve, that signals through a cytokine-type receptor rather than a receptor tyrosine kinase [#0, #1]. It assembles a tripartite receptor by first binding the ligand-specific, GPI-anchored CNTFRα and then recruiting gp130 and LIFRβ, whose heterodimerization (distinct from the gp130 homodimerization used by IL-6) drives signaling [#2, #6]; CNTFRα is both necessary and sufficient to confer CNTF responsiveness on otherwise unresponsive cells [#3]. Distinct surface determinants on CNTF mediate these contacts — a D-helix region (Gln167) for CNTFRα and residues F152/K155 for LIFRβ — and mutations combining enhanced CNTFRα affinity with disrupted LIFRβ binding yield a competitive antagonist [#10, #11]. Because CNTFRα can be shed as a soluble form that forms a 1:1 complex with CNTF and reconstitutes signaling on cells lacking membrane receptor, CNTF activity can be extended in a paracrine manner, including following nerve injury [#4, #8]. The dimerized beta receptors activate constitutively associated JAK/TYK kinases, which in turn activate STAT3; maximal STAT3 transcriptional activity additionally requires Ser727 phosphorylation contributed by mTOR, alongside PI3K/AKT and MAPK/ERK outputs [#5, #6, #14, #21]. Through these cascades CNTF supports motoneuron survival, retinal ganglion cell axon regeneration, oligodendrocyte myelination, and adult neurogenesis, and it acts peripherally on skeletal muscle to activate AMPK and reverse insulin resistance [#12, #19, #28, #23, #18]. Several CNTF effects are relayed indirectly through induced mediators — Reg-2 in motoneurons, FGF2 in the subventricular zone, and a CCL5–CCR5 axis engaging immune cells during optic nerve regeneration [#15, #23, #27]. CNTFRα additionally serves as a shared receptor component for other ligands including the CLF/CLC complex and humanin, and CNTFRα-null mice die perinatally with motoneuron deficits far exceeding those of CNTF-null mice, indicating an essential CNTFRα ligand beyond CNTF itself [#9, #13, #20]. A human CNTF null mutation is common in some populations yet is not causally linked to neurological disease, consistent with genetic redundancy among CNTF, LIF, and CT-1 in trophic support of motoneurons [#7, #12, #17].\",\n  \"teleology\": [\n    {\n      \"year\": 1989,\n      \"claim\": \"Establishing CNTF's molecular identity was the prerequisite to any mechanistic work; purification and cloning defined it as a distinct neural effector protein unrelated to known neurotrophins.\",\n      \"evidence\": \"Protein purification from rabbit sciatic nerve, cDNA cloning, and functional expression\",\n      \"pmids\": [\"2587985\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the receptor or signaling pathway\", \"No structural model of the protein\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Resolved the class of receptor CNTF uses, showing it signals via a shared cytokine receptor component (gp130) rather than a tyrosine kinase receptor like neurotrophins.\",\n      \"evidence\": \"Tyrosine phosphorylation and gene activation assays comparing CNTF, LIF and IL-6 in neuronal and hematopoietic cell lines\",\n      \"pmids\": [\"1617725\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not yet resolve full receptor subunit composition\", \"Downstream transcription factors unidentified\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Defined the tripartite receptor architecture and the specificity-determining subunit, showing CNTFRα plus heterodimerized gp130/LIFRβ form the functional complex and that CNTFRα alone confers responsiveness.\",\n      \"evidence\": \"Receptor reconstitution, co-immunoprecipitation, transfection, and cell-based response assays\",\n      \"pmids\": [\"8390097\", \"8381290\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Order of subunit assembly not yet established\", \"Cytoplasmic kinases not yet linked\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Showed CNTFRα is GPI-anchored and can act as a diffusible soluble cofactor, explaining how CNTF responsiveness can be extended beyond cells bearing membrane receptor, including after nerve injury.\",\n      \"evidence\": \"Cell-based responsiveness assays with soluble CNTFRα, CSF analysis, and muscle denervation model\",\n      \"pmids\": [\"7681218\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo physiological role of shed receptor not quantified\", \"Stoichiometry not yet defined\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Connected receptor dimerization to the intracellular signaling machinery, showing gp130/LIFRβ constitutively associate with JAK/TYK kinases activated upon ligand-induced dimerization, and biochemically defined stepwise complex assembly.\",\n      \"evidence\": \"Co-immunoprecipitation of receptor–kinase complexes, kinase activation assays, biochemical assembly analysis\",\n      \"pmids\": [\"8272873\", \"7852997\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-type-specific differences in kinase usage not mechanistically explained\", \"STAT specificity not detailed\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Defined the precise binding stoichiometry of soluble CNTFRα with CNTF, confirming a 1:1 complex that faithfully reconstitutes receptor activity and specificity.\",\n      \"evidence\": \"Size-exclusion chromatography, gel-shift assay, and TF-1 cell survival assays\",\n      \"pmids\": [\"8180210\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal structure of the complex\", \"Affinities of subsequent gp130/LIFRβ recruitment not measured here\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Tested whether CNTF is a non-redundant trophic factor in humans; a common null mutation produces no functional protein yet causes no neurological disease, revealing functional redundancy.\",\n      \"evidence\": \"Genomic sequencing, minigene transfection, mRNA analysis, and population genotyping\",\n      \"pmids\": [\"8075647\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the redundant ligands\", \"Possible subtle phenotypes not assessed\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Genetically dissociated CNTFRα from CNTF, showing CNTFRα-null mice die perinatally with motoneuron loss absent in CNTF-null mice, implying an essential second CNTFRα ligand.\",\n      \"evidence\": \"Comparative phenotyping of CNTF-/- versus CNTFRα-/- knockout mice\",\n      \"pmids\": [\"7585948\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the developmental ligand not established here\", \"Mechanism of perinatal lethality unresolved\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Mapped the CNTFRα-binding surface of CNTF and demonstrated affinity could be engineered, identifying the D-helix/Gln167 as a functional receptor-contact site.\",\n      \"evidence\": \"Phage display affinity maturation with in vitro binding and cell-based bioactivity assays\",\n      \"pmids\": [\"7621819\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"LIFRβ and gp130 contact sites not yet defined\", \"Structural basis of enhanced affinity not resolved\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Identified the distinct LIFRβ-binding determinant (F152/K155) on CNTF and exploited it to engineer a competitive receptor antagonist, separating receptor-binding functions.\",\n      \"evidence\": \"Alanine-scanning mutagenesis with binding and bioactivity assays\",\n      \"pmids\": [\"8799186\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"gp130 contact residues not mapped\", \"Antagonist in vivo efficacy not tested here\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Uncovered cryptic ligand redundancy in motoneuron support, showing LIF provides trophic support unmasked only when CNTF is also absent.\",\n      \"evidence\": \"CNTF-/-/LIF-/- double knockout with quantitative motoneuron and grip-strength analysis\",\n      \"pmids\": [\"8793295\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not include all family ligands\", \"Cellular source of compensatory LIF not defined\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identified a true second ligand for CNTFRα, the secreted CLF/CLC complex, that activates the same receptor and supports motoneuron survival.\",\n      \"evidence\": \"Co-secretion assays, STAT3 activation, receptor specificity tests, motoneuron survival assays\",\n      \"pmids\": [\"10966616\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CLF/CLC is the developmental ligand causing CNTFRα-null lethality not confirmed\", \"In vivo CLC sources not mapped\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Resolved the kinase responsible for the activating STAT3 Ser727 phosphorylation, showing mTOR rather than MAPK or PKC mediates maximal STAT3 transcriptional output downstream of CNTF.\",\n      \"evidence\": \"In vitro mTOR kinase assay, rapamycin and pathway inhibitors, dominant-negative mTOR, STAT3 Ser727Ala reporter\",\n      \"pmids\": [\"10660304\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-context generality not established\", \"Link between receptor activation and mTOR engagement not detailed\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identified an obligatory downstream mediator of CNTF motoneuron survival, showing Reg-2 acts as an autocrine/paracrine effector through PI3K-Akt-NF-κB.\",\n      \"evidence\": \"Antisense adenovirus knockdown and purified Reg-2 survival assays with pathway inhibitors in cultured motoneurons\",\n      \"pmids\": [\"11146655\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Reg-2 receptor not identified\", \"In vivo requirement of Reg-2 not tested\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Extended CNTF function to glial maturation, showing it promotes oligodendrocyte myelination via gp130 and JAK.\",\n      \"evidence\": \"Oligodendrocyte myelination index assays with JAK pathway pharmacological blockade\",\n      \"pmids\": [\"12417647\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab cell culture study without genetic validation\", \"STAT effector not identified\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Defined a species difference and receptor-substitution capacity, showing human CNTF can use IL-6Rα in place of CNTFRα but cannot engage gp130/LIFRβ without an alpha receptor.\",\n      \"evidence\": \"Cell-based signaling and receptor competition assays with chimeric constructs\",\n      \"pmids\": [\"12643274\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab functional assays\", \"Physiological relevance of IL-6Rα usage unclear\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Established a peripheral metabolic role, showing CNTF acts directly on skeletal muscle via CNTFRα-IL-6R-gp130 to activate AMPK and reverse insulin resistance independent of the brain.\",\n      \"evidence\": \"In vivo skeletal muscle AMPK activation and central-versus-peripheral pathway dissection\",\n      \"pmids\": [\"16604088\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Long-term metabolic effects not addressed here\", \"Endogenous physiological trigger unclear\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identified astrocyte-derived CNTF as a key mediator of injury-induced retinal ganglion cell protection and axon growth, acting through STAT3.\",\n      \"evidence\": \"Intravitreal CNTF neutralization, JAK inhibition, STAT3 immunostaining, and CNTF-/- comparison in vivo\",\n      \"pmids\": [\"17971355\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not separate direct from indirect effects on RGCs\", \"Relative contribution of multiple inflammatory mediators not resolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Demonstrated CNTF uses distinct signaling cascades for different outcomes and amplifies its own expression, with JAK/STAT3 and PI3K/AKT driving RGC axon growth and exogenous CNTF inducing endogenous astrocytic CNTF via MAPK/ERK.\",\n      \"evidence\": \"In vitro neurite outgrowth with pathway inhibitors, CNTF-/- mice, and MAPK/ERK inhibition in vivo\",\n      \"pmids\": [\"19332123\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism coupling receptor to ERK-driven autoinduction not detailed\", \"Quantitative contribution of autoinduction unclear\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Showed CNTFRα is co-opted by humanin to form a CNTFRα-WSX-1-gp130 neuroprotective receptor, broadening CNTFRα's ligand repertoire.\",\n      \"evidence\": \"In vitro reconstituted binding, siRNA knockdown, and receptor overexpression protection assays\",\n      \"pmids\": [\"19386761\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab study on a secondary ligand\", \"In vivo relevance not established\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Extended CNTF protection to non-neural and lower-vertebrate contexts, showing JAK2/STAT3-dependent islet protection and divergent MAPK-versus-STAT3 use for photoreceptor protection versus Müller glia proliferation.\",\n      \"evidence\": \"Pharmacological pathway inhibition and morpholino knockdown in rat islets and adult zebrafish retina\",\n      \"pmids\": [\"19272793\", \"19450453\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab pharmacological studies without genetic confirmation in mammals\", \"Cross-species generality uncertain\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identified endogenous CNTF as a driver of injury-induced adult neurogenesis acting through FGF2 induction.\",\n      \"evidence\": \"CNTF-/- mice, BrdU proliferation, MCAO stroke model, and FGF2/EGF/Notch1 expression analysis\",\n      \"pmids\": [\"22960105\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct versus FGF2-mediated effect not fully separated\", \"Receptor-bearing target cell not defined\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Defined how CNTF expression is held in check, showing neuronal contact represses astrocytic CNTF via αvβ5 integrin-FAK-JNK signaling and FAK-mediated inhibitory STAT3 Ser727 phosphorylation, with STAT3 binding the CNTF promoter.\",\n      \"evidence\": \"Integrin antibodies, FAK/JNK inhibitors, co-culture, STAT3 ChIP, and in vivo FAK inhibitor microinjection\",\n      \"pmids\": [\"23693126\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interplay between activating and inhibitory STAT3 phosphorylation not fully reconciled\", \"Thy1 receptor partner not defined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Revealed a volume-transmission neuroendocrine role, showing CRH-driven CNTF release into the ventricular system activates locus coeruleus norepinephrine synthesis via sequential ERK1 and tyrosine hydroxylase phosphorylation gated by secretagogin.\",\n      \"evidence\": \"Tract tracing, conditional CNTF/secretagogin ablation, phosphorylation and behavioral assays, human tissue validation\",\n      \"pmids\": [\"30209240\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor subunits mediating this CNS action not specified\", \"Generality across stress paradigms not exhausted\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Established CNTF as a propagator of peripheral neuroinflammation and pain, showing Schwann-cell CNTF drives STAT3-dependent IL-6 induction transmitted from periphery to spinal cord.\",\n      \"evidence\": \"CNTF-/- mice, recombinant CNTF application, pain behavior, STAT3 and IL-6 quantification in DRG and spinal cord\",\n      \"pmids\": [\"32433966\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular target of CNTF in DRG not fully defined\", \"Therapeutic window not addressed\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Showed that CNTF's regenerative effect can be largely indirect and immune-mediated, since RGC-specific CNTFRα deletion did not block optic nerve regeneration whereas a CCL5-CCR5 axis engaging immune cells did.\",\n      \"evidence\": \"Conditional CRISPR CNTFRα/CCR5 knockout, neutrophil/monocyte depletion, recombinant CCL5, and CCR5 antagonist with axon regeneration quantification\",\n      \"pmids\": [\"33627402\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative split between direct and indirect mechanisms not quantified\", \"Cell type releasing CCL5 in response to CNTF not fully resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The molecular identity of the essential developmental CNTFRα ligand responsible for the perinatal lethality of CNTFRα-null mice, and how its signaling differs from CNTF's, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No single ligand has been shown to fully account for the CNTFRα-null phenotype\", \"In vivo deconvolution of CNTF, CLC/CLF and humanin contributions through shared CNTFRα is incomplete\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [0, 2, 3, 8]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [1, 5, 6]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [10, 11]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 4, 8]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2, 3, 4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 5, 6, 14]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [26, 27]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [9, 12, 17, 23]}\n    ],\n    \"complexes\": [\n      \"CNTFRα–gp130–LIFRβ tripartite receptor complex\",\n      \"CNTF–soluble CNTFRα 1:1 ligand complex\",\n      \"CNTFRα–WSX-1–gp130 humanin receptor complex\"\n    ],\n    \"partners\": [\n      \"CNTFR\",\n      \"IL6ST\",\n      \"LIFR\",\n      \"JAK1\",\n      \"STAT3\",\n      \"MTOR\",\n      \"IL6R\",\n      \"CRLF1\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}